ARKB vs XBI
ARK 21Shares Bitcoin ETF vs SPDR S&P Biotech ETF
ARKB—
ARK 21Shares Bitcoin ETF
Spot Bitcoin ETF from ARK and 21Shares.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKB top holdings
Holdings data unavailable for ARKB.
XBI top holdings
Holdings data unavailable for XBI.
About ARKB
ARKB (ARK 21Shares Bitcoin ETF) is Spot Bitcoin ETF from ARK and 21Shares.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.